Prostate-Cancer Test Not Worth Risk, Advisory Panel Says

The PSA prostate-cancer test used by half of U.S. men older than 40 carries more risks than benefits and shouldn’t be used to diagnose the disease, a U.S. panel said, reaffirming its earlier advice.

Health experts: Routine PSA tests for prostate cancer not good for health

Task force says PSA test may give false positives and often diagnoses older men who die of other diseases before prostate cancer